- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 28.11.24 | China's NMPA grants marketing approval to Kelun-Biotech's sac-TMT for TNBC treatment | ||
| 27.11.24 | Valneva submits application seeking FDA approval for IXCHIQ for adolescent use | ||
| 26.11.24 | FDA accepts Alnylam's vutrisiran sNDA to treat ATTR-CM | ||
| 25.11.24 | FDA approves StemCyte's cord blood stem cell therapy BLA | ||
| 22.11.24 | Dyadic receives grant from Gates Foundation for RSV antibody development | ||
| 21.11.24 | Laekna partners with Lilly to develop obesity therapy | ||
| 20.11.24 | FDA grants ODD to Ractigen Therapeutics' RAG-21 for ALS treatment | ||
| 19.11.24 | Arrowhead Pharmaceuticals submits plozasiran NDA to treat FCS | ||
| 18.11.24 | Numab Therapeutics and Kaken Pharmaceutical collaborate to develop ND081 | ||
| 15.11.24 | FDA to review Sanofi, Regeneron's Dupixent sBLA for CSU | ||
| 14.11.24 | Asha Therapeutics secures grant for ALS therapeutic development | ||
| 13.11.24 | AstraZeneca and Daiichi Sankyo submit BLA to FDA for lung cancer treatment | ||
| 12.11.24 | Lakeside Holding agrees to acquires Hupan Pharmaceutical | ||
| 11.11.24 | Alteogen and Daiichi Sankyo sign license deal for ADC development | ||
| 08.11.24 | New England Biolabs opens new manufacturing facility in UK | ||
| 07.11.24 | Plus Therapeutics partners with SpectronRx for CNS therapy development | ||
| 06.11.24 | Insignis Therapeutics' IN-001 clinical programme receives positive FDA response | ||
| 05.11.24 | Ring Therapeutics signs partnerships to advance R&D in biomedical sciences | ||
| 04.11.24 | NEOGAP and NorthX Biologics partner for cancer cell therapy production | ||
| 01.11.24 | Electra Therapeutics secures FDA ODD status for HLH treatment | ||
| 31.10.24 | Shanghai Henlius Biotech, Organon announce FDA acceptance of BLA for HLX14 | ||
| 30.10.24 | FDA expands approval for Shorla's JYLAMVO to paediatric patients | ||
| 29.10.24 | Kivu Bioscience secures $92m in Series A funding for ADC development | ||
| 28.10.24 | FDA grants IND clearance for RiboX's RXRG001 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
